The company was founded in 2020 and, for five years, took not a single won of outside investment. In that time, it grew annual revenue to 60 billion won — roughly $43 million — entirely on its own brands. Then, in 2025, with that number in hand, Bytelab (바이트랩) sat investors across the table for the first time. The result was a round worth more than 10 billion won (around $7 million), with Atinum Investment and CJ Olive Young participating together.

In Korea's startup ecosystem, this story runs against the grain. The path from seed round to Series A, B, and C has hardened into something close to a standard. The default grammar of a startup goes: raise early, use the money to build a team, pour it into marketing, generate revenue, then raise again. Founding a company without investment tends to be read as "couldn't get funded," while landing a first round is read as a signal of growth.

Bytelab flipped that grammar entirely. And what came out the other end was a 10-billion-won-plus round that included a strategic partner in CJ Olive Young — the dominant health-and-beauty retail chain in Korea. What makes this more than a feel-good success story is that the timing of when to take capital is a structural question that applies just as much to solo founders, small brands, and freelancers as it does to venture-backed startups.

How Three Brands Stacked Up 60 Billion Won

Bytelab operates three brands: the haircare line Lilyeve (릴리이브), the skincare line Saekdong Seoul (색동서울), and the lifestyle brand Barner (바르너). The approach spreads categories across beauty and lifestyle while keeping operations consolidated under a single corporate entity. The 60 billion won in 2025 annual revenue, including subsidiaries, is the combined total those three brands have built.

Korea's direct-to-consumer beauty market has low barriers to entry, but brands that survive five years on their own profits are vanishingly rare. Marketing spend, more than product development or packaging, often decides who grows. And as channel dependence deepens, revenue swings with the brand's relationship to retailers like Olive Young or Coupang. Surviving five years in that environment without outside money means the company's margin structure was remarkably stable. The reasonable inference is that Bytelab didn't grow by torching investor capital on marketing — repeat purchases and unit profitability came first, brand by brand.

What matters structurally about this round is CJ Olive Young's participation as a strategic investor. Olive Young is not a firm that invests purely for financial returns. In Korea's health-and-beauty (H&B) retail market, it holds both the gatekeeping power over shelf placement and the distribution data to know what sells. For Olive Young to invest in Bytelab means a judgment had already been made: this brand portfolio is strategically valuable to its own channel. Atinum Investment, as the financial investor, will most likely take on the role of designing the medium-to-long-term exit path.

Seen this way, the round is a long way from simple fundraising. A company that has already built 60 billion won in revenue rarely raises money because it needs operating cash. What Bytelab wanted here looks less like money and more like a distribution partnership — and a restructuring of its capital base for the next stage of growth.

The Five-Year Bootstrapping Myth May Be Just That — a Myth

Here, honesty requires taking a step back.

"Five years, 60 billion won, no investment" may be a narrative constructed in reverse, after the results were in. It's hard to rule out the possibility that there were periods when the company wanted investment and couldn't get it. During the beauty D2C funding boom of 2021 and 2022, Bytelab may well have talked to investors; negotiations may simply have fallen through. The claim "we turned down investment" only holds if an acceptable offer existed in the first place. Nothing in the current reporting confirms that Bytelab has officially stated it deliberately chose not to raise.

Looked at coldly, the opportunities forfeited during those capital-starved growth years were real, too: more aggressive marketing experiments, overseas channels that could have been secured earlier, big-budget brand campaigns. Compared with competitors who used Series A money to buy brand awareness fast, Bytelab's growth rate almost certainly carried the drag of capital constraints. Bootstrapping puts an unmistakable ceiling on speed.

Romanticize Bytelab's five years and you get a myth, not a strategy. And myths are not designs that can be replicated.

Still, what the outcome reveals is unambiguous. The 60 billion won track record created a different position at the negotiating table. This was almost certainly not a conversation that began with "please invest in us," but one conducted from the seat of "we are choosing the partners we'll work with." That difference gets written into the contract — in the equity split, in the terms, in who gets to choose whom. Whether it was strategy or necessity, the bargaining position built by five years of self-funded growth was real. CJ Olive Young coming in as a strategic investor is the evidence that the position worked.

When You Take Capital Comes Before How Much

Bytelab is a startup, but the reason this case reaches solo founders and small brands is that the timing of outside capital is a structural question posed to everyone, regardless of scale.

When a freelancer gets a first offer from an agency, when a small brand is approached for a partnership by a major retailer, when a solo founder first meets a potential co-founder or angel investor — the same logic operates in every case. A deal signed before you've proven anything starts from the terms the other side proposes. A deal signed after you've proven something starts from the terms you propose.

In financial planning, when you raise has a bigger effect on the actual terms of the deal than how much you raise. Consider why the money is needed: needing capital because operations are struggling right now, versus needing capital to grow faster on top of something already proven — these two situations create entirely different positions at the negotiating table. Confuse them, and the most important decisions tend to get made at the worst possible moment.

It's also practical to figure out first what the partner wants from you. Behind CJ Olive Young's decision to make a strategic investment in Bytelab was, presumably, the goal of securing a brand portfolio suited to its own channel. Understand the partner's needs first, and you can see when — and in what form — to bring a partner in. And if you sort out whether what you actually want is money, channel access, brand credibility, or network, the criteria for choosing a partner change altogether.

The starting point, then, is to build the smallest number you can prove right now. It doesn't have to be 60 billion won. The repurchase rate on a single product, data showing one channel is actually profitable, evidence that a specific customer segment keeps coming back. These small numbers are what give your words weight when outside capital or partnerships come up for discussion.

The timing of taking capital may be one of the decisions a founder must examine most coldly. Decide when before how much — and decide first whether the terms in front of you are ones you chose, or ones you accepted.

Bytelab could choose CJ Olive Young as a partner after five years because it had first built the reasons to be chosen. Whether the company got strong because it had no outside capital, or took outside capital late because it had gotten strong, is unknowable even now. What is certain is this: the difference between holding the power to choose at the negotiating table and not holding it is preserved, line by line, in the contract itself.